BEDFORD, MA--(Marketwire - January 5, 2011) - Insulet Corporation (NASDAQ: PODD), the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, today announced the Company will participate in the J.P. Morgan 29th Annual Healthcare Conference at the Westin St. Francis Hotel in San Francisco. Management is scheduled to present an overview of the Company on Wednesday, January 12, 2011 at 2:00 p.m. PT (5:00 p.m. ET).
During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of the presentation during the events, please visit: http://investors.insulet.com. A replay of the webcast will be available for 30 days.
About Insulet Corporation
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA. For more information, please visit: www.myomnipod.com.
Contact Information:
Contact:
Stephanie Marks for Insulet Corporation
212-843-0211